Tema Cardiovascular And Etf Performance
| HRTS Etf | 29.98 0.15 0.50% |
The entity has a beta of -0.23, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Tema Cardiovascular are expected to decrease at a much lower rate. During the bear market, Tema Cardiovascular is likely to outperform the market.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Tema Cardiovascular and are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Tema Cardiovascular is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | Technical Pivots with Risk Controls - Stock Traders Daily | 01/10/2025 |
2 | Trading Signals - Stock Traders Daily | 01/31/2025 |
3 | Trading Report - Stock Traders Daily | 03/04/2025 |
Tema |
Tema Cardiovascular Relative Risk vs. Return Landscape
If you would invest 2,976 in Tema Cardiovascular and on December 25, 2024 and sell it today you would earn a total of 22.00 from holding Tema Cardiovascular and or generate 0.74% return on investment over 90 days. Tema Cardiovascular and is currently generating 0.0168% in daily expected returns and assumes 0.9387% risk (volatility on return distribution) over the 90 days horizon. In different words, 8% of etfs are less volatile than Tema, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tema Cardiovascular Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tema Cardiovascular's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Tema Cardiovascular and, and traders can use it to determine the average amount a Tema Cardiovascular's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0179
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HRTS |
Estimated Market Risk
| 0.94 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Tema Cardiovascular is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tema Cardiovascular by adding it to a well-diversified portfolio.
About Tema Cardiovascular Performance
Assessing Tema Cardiovascular's fundamental ratios provides investors with valuable insights into Tema Cardiovascular's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tema Cardiovascular is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Tema Cardiovascular is entity of United States. It is traded as Etf on NASDAQ exchange.| Latest headline from news.google.com: Trading Report - Stock Traders Daily |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tema Cardiovascular and. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of Tema Cardiovascular and is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Cardiovascular's value that differs from its market value or its book value, called intrinsic value, which is Tema Cardiovascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Cardiovascular's market value can be influenced by many factors that don't directly affect Tema Cardiovascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Cardiovascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Cardiovascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Cardiovascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.